Immunity against SARS-Coronavirus-2 in breastmilk

Recruiting

• Conditions: 10047438; Coronavirus; COVID-19

• Registration Number: NL-OMON54955
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 5000

Inclusion Criteria

- Lactating women
- For the follow-up study: participants who recieve a COVID-19 vaccination

Exclusion Criteria

• No written informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>IgG and IgA against SARS-CoV2 will be determined in the collected blood samples.<br /><br>Secretory IgA will be assessed in breast milk samples.<br /><br>Cortisol in hair will be measured</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>All the data out of the questionnaire about general health, physical activity,<br /><br>COVID-19 symptomens, diet, perceived stress.</p><br>